marketsPfizer raises 2026 outlook after strong third quarterPfizer raised its 2026 revenue and adjusted earnings forecasts after reporting third-quarter results that exceeded analyst expectations, citing demand for Eliquis and cancer medicines among the factors supporting... Coverage Mix 6 source articles Left 0% Centre 80% Right 20% 16 days agomarkets